Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
Eisai, Sumitomo, Kyowa Kirin and more—Fierce Pharma Asia
Eisai presented updated projections for Leqembi. Sumitomo plans to lay off 400 U.S. staffers. Plus more.
Angus Liu
Mar 8, 2024 9:42am
Viatris still hungry for deals after pact with Idorsia: CEO
Feb 28, 2024 10:45am
In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen
Feb 12, 2024 10:55am
Real Chemistry snaps up Avant Healthcare
Feb 6, 2024 8:05am
Novartis eyes MorphoSys buyout: Reuters
Feb 5, 2024 3:39pm
The top 10 biopharma M&A deals of 2023
Feb 5, 2024 3:00am